Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Naseer J. Basma"'
Autor:
Mark S. Williams, Naseer J. Basma, Fabio M. R. Amaral, Daniel H. Wiseman, Tim C. P. Somervaille
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-15 (2021)
Abstract Background Disease relapse remains common following treatment of acute myeloid leukemia (AML) and is due to chemoresistance of leukemia cells with disease repopulating potential. To date, attempts to define the characteristics of in vivo res
Externí odkaz:
https://doaj.org/article/44ab89e64b714d4d8eb7f6e0045fce38
Autor:
Mark S. Williams, Naseer J. Basma, Fabio M. R. Amaral, Gillian Williams, John P. Weightman, Wolfgang Breitwieser, Louisa Nelson, Stephen S. Taylor, Daniel H. Wiseman, Tim C. P. Somervaille
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Resistance to chemotherapy is the most common cause of treatment failure in acute myeloid leukemia (AML) and the drug efflux pump ABCB1 is a critical mediator. Recent studies have identified promoter translocations as common drive
Externí odkaz:
https://doaj.org/article/4b1fecc0eb29435794db48447177a4ea
Autor:
Alba Maiques-Diaz, Luciano Nicosia, Naseer J. Basma, Isabel Romero-Camarero, Francesco Camera, Gary J. Spencer, Fabio M. R. Amaral, Fabrizio Simeoni, Bettina Wingelhofer, Andrew J. K. Williamson, Andrew Pierce, Anthony D. Whetton, Tim C. P. Somervaille
Publikováno v:
Oncogene. 41:4841-4854
Pharmacologic inhibition of LSD1 induces molecular and morphologic differentiation of blast cells in acute myeloid leukemia (AML) patients harboring MLL gene translocations. In addition to its demethylase activity, LSD1 has a critical scaffolding fun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d52cd14e534c6c32cbbe50e85812e9ba
https://doi.org/10.1038/s41388-022-02471-y
https://doi.org/10.1038/s41388-022-02471-y
Autor:
Louisa Nelson, Wolfgang Breitwieser, Naseer J. Basma, Fabio M. R. Amaral, Gillian Williams, Daniel H. Wiseman, John Weightman, Stephen S. Taylor, Tim C. P. Somervaille, Mark S. Williams
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Background Resistance to chemotherapy is the most common cause of treatment failure in acute myeloid leukemia (AML) and the drug efflux pump ABCB1 is a critical mediator. Recent studies have identified promoter translocations as common drivers of hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::557342d2f369b07049818cf7d67403e4
https://doi.org/10.1186/s12885-020-07571-0
https://doi.org/10.1186/s12885-020-07571-0
Autor:
Williams, Mark S.1 (AUTHOR) mark.williams-4@manchester.ac.uk, Basma, Naseer J.1 (AUTHOR), Amaral, Fabio M. R.1 (AUTHOR), Wiseman, Daniel H.2 (AUTHOR), Somervaille, Tim C. P.1 (AUTHOR) tim.somervaille@cruk.manchester.ac.uk
Publikováno v:
BMC Cancer. 10/28/2021, Vol. 21 Issue 1, p1-15. 15p.
Autor:
Williams, Mark S.1 (AUTHOR) mark.williams-4@manchester.ac.uk, Basma, Naseer J.1 (AUTHOR), Amaral, Fabio M. R.1 (AUTHOR), Williams, Gillian2 (AUTHOR), Weightman, John P.2 (AUTHOR), Breitwieser, Wolfgang2 (AUTHOR), Nelson, Louisa3 (AUTHOR), Taylor, Stephen S.3 (AUTHOR), Wiseman, Daniel H.4 (AUTHOR), Somervaille, Tim C. P.1 (AUTHOR) tim.somervaille@cruk.manchester.ac.uk
Publikováno v:
BMC Cancer. 11/10/2020, Vol. 20 Issue 1, pN.PAG-N.PAG. 1p.